TY - JOUR
T1 - Assessing the Attainment Rates of Updated CDC Milestones Using a New Israeli Developmental Scale
AU - Sadaka, Yair
AU - Sudry, Tamar
AU - Zimmerman, Deena R.
AU - Tsadok, Meytal Avgil
AU - Baruch, Ravit
AU - Yardeni, Hadar
AU - Ben Moshe, Dror
AU - Akiva, Pinchas
AU - Amit, Guy
N1 - Publisher Copyright:
© 2022 American Academy of Pediatrics. All rights reserved.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - OBJECTIVES: Developmentalmilestones norms arewidely usedworldwide and are fundamental for early childhood developmental surveillance.We compared a new Israeli evidence-based national developmental scalewith the recently updated Centers for Disease Control and Prevention (CDC) checklists. METHODS: We used a cohort of nearly 4.5million developmental assessments of 758 300 full-term born children aged 0 to 6 years (ALL-FT cohort),who visitedmaternal child health clinics in Israel for routine developmental surveillance.Among the assessedmilestones of 4 developmental domains (grossmotor, finemotor, language, and personal-social)we identifiedmilestones that had equivalents on the CDC checklists and assessed the attainment rates of the Israeli children at the ages recommended by the CDC, atwhich$75% of the childrenwould be expected to achieve the milestone. The analysiswas repeated on a subgroup of 658 958 childrenwhowere considered healthy, typically developing by their birth and growth characteristics (NORMAL-FT cohort). RESULTS: There were 29 milestones, across all developmental domains and assessment ages, whose definitions by both tools were compatible, and could be compared. The attainment rate at the CDC-recommended age was >90% for 22 (76%) and 23 (79%) milestones, and the median attainment rates were 95.2% and 96.3% in the ALL-FT and NORMAL-FT cohorts, respectively. CONCLUSIONS: For almost all comparable milestones of all domains and all ages, children of the Israeli cohorts achieved the milestones earlier than expected by the CDC-defined threshold age. Evidence-based analysis of milestone norms among different populations may enable adjustments of developmental scales and facilitate more personalized developmental surveillance.
AB - OBJECTIVES: Developmentalmilestones norms arewidely usedworldwide and are fundamental for early childhood developmental surveillance.We compared a new Israeli evidence-based national developmental scalewith the recently updated Centers for Disease Control and Prevention (CDC) checklists. METHODS: We used a cohort of nearly 4.5million developmental assessments of 758 300 full-term born children aged 0 to 6 years (ALL-FT cohort),who visitedmaternal child health clinics in Israel for routine developmental surveillance.Among the assessedmilestones of 4 developmental domains (grossmotor, finemotor, language, and personal-social)we identifiedmilestones that had equivalents on the CDC checklists and assessed the attainment rates of the Israeli children at the ages recommended by the CDC, atwhich$75% of the childrenwould be expected to achieve the milestone. The analysiswas repeated on a subgroup of 658 958 childrenwhowere considered healthy, typically developing by their birth and growth characteristics (NORMAL-FT cohort). RESULTS: There were 29 milestones, across all developmental domains and assessment ages, whose definitions by both tools were compatible, and could be compared. The attainment rate at the CDC-recommended age was >90% for 22 (76%) and 23 (79%) milestones, and the median attainment rates were 95.2% and 96.3% in the ALL-FT and NORMAL-FT cohorts, respectively. CONCLUSIONS: For almost all comparable milestones of all domains and all ages, children of the Israeli cohorts achieved the milestones earlier than expected by the CDC-defined threshold age. Evidence-based analysis of milestone norms among different populations may enable adjustments of developmental scales and facilitate more personalized developmental surveillance.
UR - https://www.scopus.com/pages/publications/85143180920
U2 - 10.1542/peds.2022-057499
DO - 10.1542/peds.2022-057499
M3 - Article
C2 - 36398448
AN - SCOPUS:85143180920
SN - 0031-4005
VL - 150
JO - Pediatrics
JF - Pediatrics
IS - 6
M1 - e2022057499
ER -